Profile data is unavailable for this security.
About the company
Venus Remedies Ltd is a research-based pharmaceutical company. The Company is a global injectable manufacturer, possessing a wide product basket catering to therapeutic segments of anti-infective specially in antimicrobial resistance (AMR), oncology, skin and wound care and pain management. The Company operates in the Pharmaceutical Formulation segment. It manufactures products catering to the critical care and super specialty segments. The Company's product portfolio includes formulations such as injectables, tablets, and topical preparations. The Company offers solutions in the domains of antimicrobial resistance (AMR), oncology, skin & wound care, neurology, anticoagulants, pain management, herbal portfolio and disinfectants. Its focus therapy areas include medicine, surgery, neuro and orthopedics. The Company’s brands include Potentox, Vancoplus Combi, Tobracef, Supime, Zydotum, Neurotol, Trois, Septiloc, Mucomelt, Ventaful and Nervolize. It has three manufacturing facilities.
- Revenue in INR (TTM)5.62bn
- Net income in INR290.26m
- Incorporated1989
- Employees998.00
- LocationVenus Remedies Ltd51-52, Industrial Area, Phase-1PANCHKULA 134113IndiaIND
- Phone+91 1 722933090
- Fax+91 1 722565566
- Websitehttps://www.venusremedies.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Par Drugs and Chemicals Ltd | 956.40m | 145.01m | 3.01bn | 105.00 | 20.78 | 3.52 | 16.79 | 3.15 | 11.78 | 11.78 | 77.72 | 69.59 | 1.00 | 7.07 | 6.23 | -- | 15.23 | 13.52 | 17.68 | 16.46 | 64.67 | 50.26 | 15.16 | 13.42 | 4.46 | 180.96 | 0.00 | -- | -0.1132 | 15.60 | 27.94 | 42.01 | 77.72 | -- |
| Medico Remedies Ltd | 1.45bn | 82.91m | 3.16bn | -- | 38.43 | 6.03 | 28.27 | 2.18 | 0.99 | 0.99 | 17.31 | 6.31 | 1.58 | 6.10 | 3.38 | -- | 9.03 | 6.15 | 16.70 | 12.40 | 24.16 | 25.26 | 5.72 | 3.99 | 1.34 | 12.18 | 0.1332 | -- | 3.19 | 8.21 | 14.49 | 39.49 | -7.58 | -- |
| Take Solutions Ltd | 850.73m | -113.89m | 3.54bn | 211.00 | -- | -- | -- | 4.16 | -0.7833 | -4.44 | 5.90 | -- | -- | -- | -- | 4,031,915.00 | -- | -4.65 | -- | -7.25 | 55.38 | 71.04 | -13.49 | -7.07 | -- | 1.07 | -- | -- | -71.03 | -34.66 | 43.41 | -- | -44.31 | -- |
| Lyka Labs Ltd | 1.06bn | -35.60m | 3.93bn | 713.00 | -- | -- | 39.97 | 3.72 | -1.23 | -1.23 | 33.69 | -- | -- | -- | -- | -- | -- | -5.48 | -- | -9.31 | 61.37 | 59.75 | -3.34 | -10.63 | -- | 0.5422 | -- | -- | -52.05 | 8.95 | -133.88 | -- | 17.78 | -- |
| Venus Remedies Ltd. | 5.62bn | 290.26m | 3.98bn | 998.00 | 13.72 | -- | 6.89 | 0.709 | 21.73 | 21.73 | 420.31 | -- | -- | -- | -- | 5,630,556.00 | -- | 2.84 | -- | 3.84 | 42.76 | 39.68 | 5.17 | 3.83 | -- | 559.36 | -- | -- | -7.21 | 8.33 | -34.77 | -- | -10.05 | -- |
| Wanbury Ltd | 5.76bn | 559.56m | 4.87bn | 1.58k | 8.70 | 17.42 | 7.06 | 0.8456 | 17.09 | 17.09 | 175.71 | 8.53 | 1.78 | 10.43 | 7.27 | -- | 17.30 | 11.63 | 99.14 | -- | 47.43 | 43.79 | 9.72 | 7.62 | 0.5757 | 1.95 | 0.8065 | -- | 15.21 | 8.02 | 638.26 | -- | 29.87 | -- |
